The Latest

This Week in HIV Research: The Racism of Perceived Risk

June 6, 2019: HIV/STI risk perceptions differ by race; psychosocial issues and HIV risk among young trans women; switching to dolutegravir/atazanavir; reports of severe hepatotoxicity on dolutegravir.

By Barbara Jungwirth and Myles Helfand

Why Do Study Participants Misreport Their HIV Status?

A new study demonstrates the phenomenon, but experts say more research needs to determine why it occurs -- and what researchers can do differently to reduce it.

By Barbara Jungwirth

This Week in HIV Research: A Long-Acting Popularity Contest

The most popular form of long-acting HIV treatment; telehealth for PrEP uptake among young MSM of color; PrEP awareness and usage among Rhode Island women; assessing cognitive benefits of switching off of efavirenz.

By Barbara Jungwirth and Myles Helfand

African-American Men and HIV Treatment Outcomes: A Top HIV Clinical Development of 2018

The HIV pandemic, like the virus itself, is opportunistic and parasitic. AIDS is a disease of poverty, disruption, stigma, and chaos. Wherever the social fabric is torn, HIV enters and occupies. Wherever communities struggle, HIV thrives. Here in the...

By David Alain Wohl, M.D.

This Week in HIV Research: Vitamin D for CD4? Eh.

The effect of vitamin D levels on CD4 count during HIV treatment; helping black men who have sex with men utilize PrEP; HIV and aortic stiffness; Legionnaires’ disease severity among people with HIV.

By Barbara Jungwirth and Myles Helfand

Making HIV -- and Bias -- 'Part of the Party' to Strengthen Our Response to the Epidemic

Not talking about HIV does not lead to HIV ceasing to be a profound public health challenge; the same is true for the explicit and implicit biases that underpin the HIV response. Marsha Martin, D.S.W., discusses ways to remove the harm of bias on a w...

By Olivia G. Ford

Bias Is Everywhere: Uncovering HIV Prejudice to Improve Service Delivery

"All disparities in HIV are connected to the biases," proclaimed HIV public health veteran Marsha Martin, D.S.W., in a workshop at September's U.S. Conference on AIDS (USCA); "and we need to figure out how we are going to take them on."

By Olivia G. Ford

How to Reverse Implicit Bias in HIV Care: 6 Steps to Take Today

We caught up with speakers and presenters at a major HIV community meeting to learn how HIV care providers can uncover and remove the harm of bias in their work.

By Olivia G. Ford

More Cognitive Activity Tied to Better Neurocognition in Older African Americans With HIV

A recent study linked more cognitive activity to better cognitive performance in older African Americans with HIV infection.

By Mark Mascolini

Times to Starting Treatment and Viral Suppression Drop 40% in U.S. Group, but Slower for African Americans

Times from HIV diagnosis to starting antiretroviral therapy and to viral suppression dwindled more than 40% from 2000 to 2013, according to the HIV Outpatient Study (HOPS). However, compared with whites, African Americans had significantly slower tim...

By Mark Mascolini